{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:04:54Z","timestamp":1790949894497,"version":"4.1.0"},"reference-count":29,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"unspecified","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"NIHR","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100020624","name":"Nottingham Biomedical Research Centre","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100020624","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2025,7,9]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Interstitial lung disease (ILD) represents a group of complex parenchymal conditions characterised by varying clinical trajectories. The It\u2019s Not JUST Idiopathic Pulmonary Fibrosis Study seeks to identify genetic, proteomic and clinical biomarkers that distinguish rapidly progressive fibrotic phenotypes from stable phenotypes irrespective of aetiology. This manuscript presents baseline insights from the recruited cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective, longitudinal study, participants with fibrotic ILDs, including idiopathic pulmonary fibrosis (IPF), fibrotic hypersensitivity pneumonitis, rheumatoid arthritis-associated ILD, asbestosis and unclassifiable ILD, were enrolled from 24 UK sites. Participants underwent comprehensive baseline evaluation including demographics, exposure history, lung function testing, 6-min walk tests, blood sampling and standardised questionnaires to assess symptoms and quality of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 272 participants were recruited, predominantly older white males with a smoking history. Baseline lung function showed comparable forced vital capacity (mean 89.0% predicted), diffusion of carbon monoxide (mean 57.9% predicted) and 6-min walk distance (mean 302 m) across ILD subtypes. Hypertension was the most prevalent comorbidity, affecting 40.8% of participants, with no significant differences across subtypes. Anxiety and depression were notably lower in IPF than non-IPF (4.5%; 21.0%). Previous occupational exposure was reported in 68.8% of participants, with asbestos exposure the most prevalent (36%). Bird exposure was reported by 40.4% of participants, with no significant differences across subtypes. No significant differences in health-related quality of life scores were observed across subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Despite varied aetiologies, fibrotic ILDs exhibit demographic and functional similarities, including lung function and health-related quality of life suggesting commonalities in disease mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT03670576\">NCT03670576<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2024-003112","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T14:35:19Z","timestamp":1768919719000},"page":"e003112","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Comprehensive characterisation of individuals with fibrotic interstitial lung disease: baseline insights from the INJUSTIS study"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct03670576","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03670576","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0796-5724","authenticated-orcid":false,"given":"Fasihul","family":"Khan","sequence":"first","affiliation":[{"name":"Respiratory Medicine, University of Nottingham, Nottingham, UK"},{"name":"Respiratory Medicine, University Hospitals of Leicester NHS Trust, Leicester, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1340-2688","authenticated-orcid":false,"given":"Iain","family":"Stewart","sequence":"additional","affiliation":[{"name":"National Heart & Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Howard","sequence":"additional","affiliation":[{"name":"Adelphi Real World, Bollington, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2234-4165","authenticated-orcid":false,"given":"Christopher Michael","family":"Barber","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2292-4103","authenticated-orcid":false,"given":"Rebecca","family":"Borton","sequence":"additional","affiliation":[{"name":"Patientmpower Ltd, Dublin, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Braybrooke","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Hearson","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Jones","sequence":"additional","affiliation":[{"name":"Action for Pulmonary Fibrosis, Peterborough, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Maher","sequence":"additional","affiliation":[{"name":"USC Keck School of Medicine, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Matthews","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gauri","family":"Saini","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Thompson","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, Nottingham Respiratory Research Unit, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M","family":"Wilson","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia, Norwich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9837-2763","authenticated-orcid":false,"given":"Simon R","family":"Johnson","sequence":"additional","affiliation":[{"name":"Respiratory Medicine, University of Nottingham, Nottingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7929-2119","authenticated-orcid":false,"given":"Gisli","family":"Jenkins","sequence":"additional","affiliation":[{"name":"National Heart and Lung Institute, Imperial College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"2026012006351374000_13.1.e003112.1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0399ST"},{"key":"2026012006351374000_13.1.e003112.2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S2213-2600(17)30216-3","article-title":"The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study","volume":"5","author":"Ley","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2026012006351374000_13.1.e003112.3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201902-0360OC"},{"key":"2026012006351374000_13.1.e003112.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681"},{"key":"2026012006351374000_13.1.e003112.5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202201-0124OC"},{"key":"2026012006351374000_13.1.e003112.6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01612-2021","article-title":"A systematic review of blood biomarkers with individual participant data meta-analysis of matrix metalloproteinase-7 in idiopathic pulmonary fibrosis","volume":"59","author":"Khan","year":"2022","journal-title":"Eur Respir J"},{"key":"2026012006351374000_13.1.e003112.7","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S2213-2600(17)30430-7","article-title":"An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study","volume":"5","author":"Maher","year":"2017","journal-title":"Lancet Respir Med"},{"key":"2026012006351374000_13.1.e003112.8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2019-000439","article-title":"The Its Not JUST Idiopathic pulmonary fibrosis Study (INJUSTIS): description of the protocol for a multicentre prospective observational cohort study identifying biomarkers of progressive fibrotic lung disease","volume":"6","author":"Khan","year":"2019","journal-title":"BMJ Open Respir Res"},{"key":"2026012006351374000_13.1.e003112.9","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00357-2015"},{"key":"2026012006351374000_13.1.e003112.10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1255ST"},{"key":"2026012006351374000_13.1.e003112.11","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1590ST"},{"key":"2026012006351374000_13.1.e003112.12","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00034805"},{"key":"2026012006351374000_13.1.e003112.13","doi-asserted-by":"publisher","DOI":"10.1183\/20734735.012717"},{"key":"2026012006351374000_13.1.e003112.14","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202205-0963OC"},{"key":"2026012006351374000_13.1.e003112.15","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.58.4.339"},{"key":"2026012006351374000_13.1.e003112.16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5213.1665"},{"key":"2026012006351374000_13.1.e003112.17","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01925-2018","article-title":"Patient-reported distress can aid clinical decision-making in idiopathic pulmonary fibrosis: analysis of the PROFILE cohort","volume":"53","author":"Stewart","year":"2019","journal-title":"Eur Respir J"},{"key":"2026012006351374000_13.1.e003112.18","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-201581"},{"key":"2026012006351374000_13.1.e003112.19","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-011-9903-x"},{"key":"2026012006351374000_13.1.e003112.20","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200602-163OC"},{"key":"2026012006351374000_13.1.e003112.21","doi-asserted-by":"publisher","DOI":"10.1136\/oemed-2022-108404"},{"key":"2026012006351374000_13.1.e003112.22","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.chest.2021.01.026","article-title":"Family History of Pulmonary Fibrosis Predicts Worse Survival in Patients With Interstitial Lung Disease","volume":"159","author":"Cutting","year":"2021","journal-title":"Chest"},{"key":"2026012006351374000_13.1.e003112.23","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104356","article-title":"Mapping brain endophenotypes associated with idiopathic pulmonary fibrosis genetic risk","volume":"86","author":"Mohammadi-Nejad","year":"2022","journal-title":"EBioMedicine"},{"key":"2026012006351374000_13.1.e003112.24","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.680997","article-title":"Biomarkers in Progressive Fibrosing Interstitial Lung Disease: Optimizing Diagnosis, Prognosis, and Treatment Response","volume":"8","author":"Bowman","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2026012006351374000_13.1.e003112.25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/qjmed\/hcad050","article-title":"Classifying the unclassifiable-a Delphi study to reach consensus on the fibrotic nature of diseases","volume":"116","author":"Massen","year":"2023","journal-title":"QJM"},{"key":"2026012006351374000_13.1.e003112.26","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00376-2016"},{"key":"2026012006351374000_13.1.e003112.27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1164\/ajrccm\/145.1.1","article-title":"Controversies in Hypersensitivity Pneumonitis","volume":"145","author":"Rose","year":"1992","journal-title":"Am Rev Respir Dis"},{"key":"2026012006351374000_13.1.e003112.28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S2213-2600(13)70191-7","article-title":"Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study","volume":"1","author":"Morell","year":"2013","journal-title":"Lancet Respir Med"},{"key":"2026012006351374000_13.1.e003112.29","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S2213-2600(15)00048-X","article-title":"Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study","volume":"3","author":"Jenkins","year":"2015","journal-title":"Lancet Respir Med"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2024-003112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T14:35:22Z","timestamp":1768919722000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2024-003112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,20]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/bmjresp-2024-003112"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2024-003112","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}